Literature DB >> 26391536

Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.

L Deforche1, E Roose1, A Vandenbulcke1, N Vandeputte1, H B Feys2, T A Springer3, L Z Mi3, J Muia4, J E Sadler4, K Soejima5, H Rottensteiner6, H Deckmyn1, S F De Meyer1, K Vanhoorelbeke1.   

Abstract

BACKGROUND: Recently, conformational activation of ADAMTS-13 was identified. This mechanism showed the evolution from a condensed conformation, in which the proximal MDTCS and distal T2-CUB2 domains are in close contact with each other, to an activated, open structure due to binding with von Willebrand factor (VWF).
OBJECTIVES: Identification of cryptic epitope/exosite exposure after conformational activation and of sites of flexibility in ADAMTS-13.
METHODS: The activating effect of 25 anti-T2-CUB2 antibodies was studied in the FRETS-VWF73 and the vortex assay. Cryptic epitope/exosite exposure was determined with ELISA and VWF binding assay. The molecular basis for flexibility was hypothesized through rapid automatic detection and alignment of repeats (RADAR) analysis, tested with ELISA using deletion variants and visualized using electron microscopy.
RESULTS: Eleven activating anti-ADAMTS-13 antibodies, directed against the T5-CUB2 domains, were identified in the FRETS-VWF73 assay. RADAR analysis identified three linker regions in the distal domains. Interestingly, identification of an antibody recognizing a cryptic epitope in the metalloprotease domain confirmed the contribution of these linker regions to conformational activation of the enzyme. The proof of flexibility around both the T2 and metalloprotease domains, as shown by by electron microscopy, further supported this contribution. In addition, cryptic epitope exposure was identified in the distal domains, because activating anti-T2-CUB2 antibodies increased the binding to folded VWF up to ~3-fold.
CONCLUSION: Conformational activation of ADAMTS-13 leads to cryptic epitope/exosite exposure in both proximal and distal domains, subsequently inducing increased activity. Furthermore, three linker regions in the distal domains are responsible for flexibility and enable the interaction between the proximal and the T8-CUB2 domains.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  ADAMTS-13 protein, human; allosteric regulation; autoantibodies; protein conformation; von Willebrand factor

Mesh:

Substances:

Year:  2015        PMID: 26391536      PMCID: PMC4778570          DOI: 10.1111/jth.13149

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  43 in total

1.  Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2.

Authors:  Xing Chen; Can Xie; Noritaka Nishida; Zongli Li; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

2.  Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.

Authors:  Masashi Akiyama; Soichi Takeda; Koichi Kokame; Junichi Takagi; Toshiyuki Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

3.  A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.

Authors:  Yue Han; Juan Xiao; Erica Falls; X Long Zheng
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

4.  Unfolding the A2 domain of von Willebrand factor with the optical trap.

Authors:  Junyi Ying; Yingchen Ling; Lisa A Westfield; J Evan Sadler; Jin-Yu Shao
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

5.  Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

Authors:  Hendrik B Feys; Jan Roodt; Nele Vandeputte; Inge Pareyn; Seb Lamprecht; Walter J van Rensburg; Patricia J Anderson; Ulrich Budde; Vernon J Louw; Philip N Badenhorst; Hans Deckmyn; Karen Vanhoorelbeke
Journal:  Blood       Date:  2010-06-15       Impact factor: 22.113

6.  Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.

Authors:  H B Feys; N Vandeputte; R Palla; F Peyvandi; K Peerlinck; H Deckmyn; H R Lijnen; K Vanhoorelbeke
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

7.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

8.  Multi-step binding of ADAMTS-13 to von Willebrand factor.

Authors:  H B Feys; P J Anderson; K Vanhoorelbeke; E M Majerus; J E Sadler
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

9.  Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13.

Authors:  Tao Wu; Jiangguo Lin; Miguel A Cruz; Jing-fei Dong; Cheng Zhu
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

10.  A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Authors:  Sara Zanardelli; Alain C K Chion; Evelyn Groot; Peter J Lenting; Thomas A J McKinnon; Mike A Laffan; Michelle Tseng; David A Lane
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

View more
  21 in total

1.  Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation.

Authors:  Lara Zafrani; Charlotte Dekimpe; Bérangère S Joly; Elien Roose; Fabienne Fieux; Elie Azoulay; Marie-Noëlle Peraldi; Antoine Durrbach; Paul Coppo; Karen Vanhoorelbeke; Agnès Veyradier
Journal:  Haematologica       Date:  2019-02-28       Impact factor: 9.941

2.  Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.

Authors:  Jian Zhu; Joshua Muia; Garima Gupta; Lisa A Westfield; Karen Vanhoorelbeke; Niraj H Tolia; J Evan Sadler
Journal:  Blood       Date:  2019-01-28       Impact factor: 22.113

Review 3.  ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.

Authors:  Konstantine Halkidis; X Long Zheng
Journal:  J Thromb Haemost       Date:  2022-08-03       Impact factor: 16.036

4.  Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.

Authors:  Derek J B Kleinveld; Derek D G Simons; Charlotte Dekimpe; Shannen J Deconinck; Pieter H Sloos; M Adrie W Maas; Jesper Kers; Joshua Muia; Karim Brohi; Jan Voorberg; Karen Vanhoorelbeke; Markus W Hollmann; Nicole P Juffermans
Journal:  Blood Adv       Date:  2021-09-14

5.  Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Authors:  Joshua Muia; Jian Zhu; Suellen C Greco; Karen Vanhoorelbeke; Garima Gupta; Lisa A Westfield; J Evan Sadler
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

6.  Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function.

Authors:  An-Sofie Schelpe; Anastasis Petri; Elien Roose; Inge Pareyn; Hans Deckmyn; Simon F De Meyer; James T B Crawley; Karen Vanhoorelbeke
Journal:  Blood Adv       Date:  2020-03-24

7.  Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Louis Deforche; Claudia Tersteeg; Elien Roose; Aline Vandenbulcke; Nele Vandeputte; Inge Pareyn; Elien De Cock; Hanspeter Rottensteiner; Hans Deckmyn; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

8.  A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.

Authors:  Kieron South; Marta O Freitas; David A Lane
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

Review 9.  Monoclonal antibodies against metzincin targets.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

10.  Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill.

Authors:  Lisa van Manen; Maike E van Hezel; Margit Boshuizen; Marleen Straat; Angelique M E de Man; Charlotte Dekimpe; Karen Vanhoorelbeke; Robin van Bruggen; Nicole P Juffermans
Journal:  Vox Sang       Date:  2021-07-01       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.